Life Science Tools and Services Market Size, Share, Industry Growth Analysis, and Forecast to 2029

The global life science tools and services market is set to witness a growth rate of 10-11% in the next 5 years. Rising demand for biologics and biosimilars, technological advancements in life science tools, increased government funding for life science technologies, increased adoption of advanced technologies such as sequencing and chromatography, and growing focus on food testing and environmental health are some of the key factors driving the market growth. To learn more about the research report, download a sample report.

Report Overview

Life science- is an umbrella term that studies organisms and microorganisms. Different fields fall under life science such as cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry. The life science tools and services market is segmented based on technique, products & services and end user.

Technological Advancements in Life Science Tools and Services Market to Fuel Its Global Demand

Continuous advancements in thelife science tools and services market have enabled the development of efficient products with advanced capabilities, increased applications, and cost-effectiveness. Such advancements tend to provide acompetitive edge to manufacturers. Therefore, major players are continuously investing in research activities for new product development and expanding their geographic reach to strengthen their position in the life science tools and services market. Some of the technological advanceelow:

• In May 2024, Agilent Technologies Inc. introduced the 8850 Gas Chromatograph, a compact, energy-efficient system that merges the legacy of the 6850 GC with the intelligence and capabilities of the 8890 GC, designed to enhance laboratory efficiency across industries like energy, chemicals, food, and pharmaceuticals
• In December 2023, Merck introduced AIDDISON the first AI-driven drug discovery software that integrates virtual molecule design with real-world manufacturability by combining generative AI, machine learning, and Synthia retrosynthesis API to enhance drug discovery and synthesis processes.
• In August 2022,Rochelaunched its Digital Light Cycler System, a next-generation digital PCR system to assist clinical researchers in better understanding the nature of a patient-s infection, genetic disease or cancer, leading to early diagnosis
• In June 2022,Waters Corporationintroduced theNew Xevo G3 quadrupole time-of-flight mass spectrometer, a more sensitive spectrometer than its predecessor to drive drug discovery and development
• In May 2022,Bio-Rad Laboratories, Inc.launched the CFX Duet Real-Time PCR System to help researchers develop singleplex and duplex quantitative PCR (qPCR) assays by offering a robust thermal performance featuring its proprietary and accurate optical shuttle system
• In March 2022,hed its benchtop sequencer - Element AVITI System, which offers acombination of performance, cost, and flexibility in an unprecedented way. This system consists of a benchtop NGS instrument and related consumables
• In August 2021, Becton, Dickinson and Company launched its benchtop cell analyzer -FACSymphony A1-, offering new capabilities to researchers in small as well as large labs by performing exploratory experiments without tying up freestanding cell analyzers
"aligncenter wp-image-6798 size-full" src="https://meditechinsights.com/wp-content/uploads/2023/03/Life-Science-Tools-and-Services-Market.png" alt="Life Science Tools and Services Market" width="898" height="505" />

To learn more about this report, download the PDF brochure

Emerging Opportunities in the Life Science Tools and Services Market

• Greater Acceptance of Genomics
  • NCCN guideline adoption: The National Comprehensive Cancer Network (NCCN) has recommended theadoption of genetic panel testing in ovarian and breast cancer testing, to help find mutations
  • Shift towards consumerism: Shift towards a more consumer-oriented model is expected to drive the demand for genomic technologies to understand future health outcomes
• Bioproduction, a fast-growing area
  • Growth within biosimilars: The biosimilars market exhibits a high CAGR due to low cost and increased demand which further drive the expansion of the bioproduction industry
  • Access to healthcare in emerging markets: Large molecule drugs have seen high growth in emerging markets and is expected that pharmerging economies will drive the medicine volume usage in next five years
• Focus on Food Testing & Environmental Health
  • Food testing:Increased global food safety regulations, corporate brand management, and increasing emphasis on efficient livestock and agricultural production have contributed to thegrowth of thelife science tools and services market for food testing
  • Environmental health:Improving thequality of the soil, air, ning up pollutants falls under theenvironmental health agenda. Governments now seem to be more committed to these programs for better quality

North America is expected to hold a major share in the Global Life Science Tools and Services Market

From a geographical perspective, North America holds a major market share of the life science tools and services market. This can be mainly attributed to the growing number of genomic procedures, rapid growth in biologics coupled with opportunities in biosimilars, and increased access to advanced technologies. However, the Asia Pacific is expected to ascend at the fastest CAGR over the forecast period on account of the large customer base and growing health concerns in key markets such as Japan, China & India and theincreasing focus of major players on pharmaceutical R&D outsourcing.

Competitive Landscape Analysis

The global life science tools and services market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Becton; Dickinson and Company; Bio-Rad Laboratories, Inc.; Merck KGaA; Danaher Corporation; Illumina, Inc.; Thermo Fisher Scientific, Inc; QIAGEN N.V.; Shimadzu Corporation; Hitachi Ltd.; Bruker Corporation; Oxford Instruments plc; and Zeiss International among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, and acquisitions to garner market share. For instance,

• In September 2024, Agilent Technologies Inc. finalized its acquisition of BIOVECTRA, specializing in biologics, highly potent active pharmaceutical ingredients, and molecules for targeted therapeutics, expanding its specialized CDMO offerings for pharmaceutical customers
• In November 2023, Thermo Fisher Scientific and Flagship Pioneering announced a strategic partnership aimed at developing and scaling multiproduct platforms, focusing on establishing new companies that will leverage innovative tools and capabilities to expedite therapy development
• In January 2023, Agilent Technologies Inc. announced its acquisition of Avida Biomed, a life sciences company specializing in high-performance NGS target enrichment workflows that enable simultaneous genomic and epigenomic profiling for cancer research, aimed at advancing precision medicine

The market continues to evolve with ongoing research, technological innovations, an increasing focus on precision medicine, increasing government funding and aggressive organic and inorganic growth strategies followed by the players.

Report Scope

Report Scope	Details
Base Year Considered	2023
Historical Data	2022 - 2023
Forecast Period	2024 - 2029
Growth Rate	CAGR of 10-11%
Market Drivers	Rising demand for biologics and biosimilars Technological advancements in life science tools Increased government funding for life science technologies Growing focus on food testing and environmental health Increasing adoption of advanced technologies like sequencing and chromatography
Attractive Opportunities	Increased focus on precision medicine Growth in pharmaceutical R&D outsourcing in emerging markets
Segment Scope	Technique, Product & Services, End User
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	F. Hoffmann-La Roche Ltd.; Agilent Technologies, Inc.; Becton; Dickinson and Company; Bio-Rad Laboratories, Inc.; Merck KGaA; Danaher Corporation; Illumina, Inc.; Thermo Fisher Scientific, Inc; QIAGEN N.V.; Shimadzu Corporation; Hitachi Ltd.; Bruker Corporation; Oxford Instruments plc; and Zeiss International
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides size of the Life Science Tools and Services at a regional level from 2022 to 2029. The report further segments the market on the basis of technique, product & services, and end user.

Market Size & Forecast (2022-2029), By Technique, USD Million

• Next-Generation Sequencing (NGS)
• PCR (Polymerase chain reaction) & qPCR (quantitative polymerase chain reaction)
• Flow Cytometry
• Nuclear Magnetic Resonance Spectroscopy (NMR)
• Microscopy & Electron Microscopy
• Liquid Chromatography (LC)
• Mass Spectrometry (MS)
• Nucleic Acid Preparation (NAP)
• Transfection Devices & Gene Delivery Technologies
• Cell Culture Systems & 3D Cell Culture
• Cloning & Genome Engineering
• Nucleic Acid Microarray
• Sanger Sequencing

Market Size & Forecast (2022-2029), By Products & Services, USD Million

• Instruments
• Reagents and Consumables
• Software
• Services

Market Size & Forecast (2022-2029), By End User, USD Million

• Biopharmaceutical Companies
• Academic and Research Institutes
• Hospitals
• Diagnostic Centers
• Others

Market Size & Forecast (2022-2029), By Region, USD Million

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa



To learn more about this report, download the PDF brochure

Key Strategic Questions Addressed

• What is the market size & forecast of the life science tools and services market?

• What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the life science tools and services market?

• What are the key trends defining the market?

• What are the major factors impacting the market?

• What are the opportunities prevailing in the market?

• Which region has the highest share in the global market?

• Which region is expected to witness the highest growth rate in the next 5 years?

• Who are the major players operating in the market?

• What are the key strategies adopted by players?